Alchemab Therapeutics

Alchemab Therapeutics is a biotechnology company headquartered in Cambridge, UK, developing new products for patients with diseases by leveraging naturally protective antibodies. Alchemab Therapeutics has developed a platform that identifies novel drug targets and therapeutics based on patient B-cell antibody repertoires. Alchemab is building a portfolio of protective therapies for difficult-to-treat conditions, with an initial focus on oncology, neurodegenerative diseases, and infectious diseases.